On the contrary, the upregulation of RIPK3 inhibited FAO via the suppression of PPAR activation, and could reverse the immunosuppressive activity of TAMs and dampen HCC tumorigenesis [109], and inhibition of FAO in TAMs promoted the anti-tumorigenic differentiation of TAMs and inhibited tumor growth [110]. The gene discussed is RIPK3; the disease is neoplasm.